U.S. FDA flags probable cancer-causing impurity in common heartburn drugs
Reuters: Health
The U.S. Food and Drug Administration said on Friday that some medicines containing ranitidine, including Sanofi SA's Zantac, had traces of a probable cancer-causing impurity called N-nitrosodimethylamine (NDMA) at low levels.
Subscribe to:
Post Comments (Atom)
Subscribe UsPopular Posts
|
No comments:
Post a Comment